**Patient Discharge Summary**

**Patient Details:**  
Name: John Doe  
Age: 58 years  
Sex: Male  
Admission Date: September 15, 2023  
Discharge Date: September 22, 2023  
Admitting Physician: Dr. Jane Smith, Cardiovascular Unit

**Presenting Complaint:**  
The patient presented to the emergency department on September 15, 2023, with complaints of persistent headaches and episodes of dizziness over the past two weeks. He reported a family history of hypertension but had not been previously diagnosed or treated for the condition.

**Medical History:**  
- Family history of hypertension and coronary artery disease.  
- No history of diabetes mellitus or chronic kidney disease.  
- Non-smoker, moderate alcohol use.  
- Medications upon admission: None.

**Physical Examination Upon Admission:**  
- Blood pressure: 162/98 mm Hg in the right arm, 160/96 mm Hg in the left arm.  
- Height: 175 cm, Weight: 89 kg, BMI: 29.1, Waist circumference: 102 cm.  
- Physical examination was otherwise unremarkable with no signs of target organ damage.

**Diagnostic Testing:**  
- Urinalysis, lipid panel, comprehensive metabolic panel, fasting plasma glucose, and thyroid-stimulating hormone levels were within normal limits.  
- ECG showed no signs of left ventricular hypertrophy or ischemia.  
- Home BP monitoring was initiated, confirming persistent elevated blood pressure readings averaging 158/92 mm Hg over a 7-day period.

**Hospital Course:**  
John Doe was admitted to the cardiovascular unit for further evaluation and management of newly diagnosed arterial hypertension. Initial management focused on lifestyle modifications, including dietary advice for reduced sodium intake (<1500 mg/day) and initiation of a structured physical activity program. Despite these measures, his blood pressure remained above target levels.

**Medication Initiated:**  
Given his persistent hypertension, pharmacological treatment was initiated on September 17, 2023, with:
- Lisinopril 10 mg orally, once daily.
- Hydrochlorothiazide 25 mg orally, once daily.

The patient demonstrated good tolerance to the initial medication regimen with no adverse effects. Blood pressure monitoring showed a gradual decline in readings, achieving target levels of <130/80 mm Hg by September 20, 2023.

**Education:**  
The patient received comprehensive education on the importance of adherence to prescribed therapies, lifestyle modifications, and regular blood pressure monitoring at home. He was instructed on the correct technique for BP measurement and the need for regular follow-up appointments with his primary care physician.

**Follow-Up:**  
- A follow-up appointment was scheduled with Dr. Jane Smith for October 20, 2023, for reassessment of blood pressure control and medication management.
- The patient was advised to return to the emergency department if he experienced symptoms of hypertensive emergencies or adverse effects related to medication.

**Discharge Medications:**  
- Lisinopril 10 mg orally, once daily.  
- Hydrochlorothiazide 25 mg orally, once daily.

**Summary:**  
John Doe was admitted with newly diagnosed arterial hypertension and was managed with a combination of lifestyle modifications and pharmacotherapy, achieving target blood pressure levels prior to discharge. The patient demonstrated an understanding of his condition and the importance of ongoing management, including medication adherence and lifestyle changes. Regular follow-up was arranged to ensure continued control of his hypertension and prevention of potential complications.

**Discharge Instructions:**  
- Continue with prescribed medications without interruption.  
- Monitor blood pressure at home twice daily and maintain a log.  
- Adhere to lifestyle recommendations, including dietary changes and physical activity.  
- Schedule and attend all follow-up appointments.  
- Be vigilant for symptoms of potential complications or side effects from medications and seek medical attention as needed.

**Physician's Signature:**  
Dr. Jane Smith, MD  
Cardiovascular Unit